Literature DB >> 54335

Molecular construction of Clostridium botulinum type A toxins.

S Sugii, G Sakaguchi.   

Abstract

Two Clostridium botulinum type A toxic fractions, named large (L) and medium (M) toxins, were eluted from Sephadex G-200. Sucrose density gradient centrifugation resolved L toxin (2.5 X 10(8) to 3.0 X 10(8) mean lethal doses per mg of N) into two fractions, 19S and 16S. The same procedure performed at pH 8resolved it into three fractions; the heavier two were both nontoxic and hemagglutinin positive, and the lightest on (7S) was toxic. M toxin (12S) (4.5 X 10(8) to 5.0 X 10(8) mean lethal doses per mg of N) was homogeneous in electrophoresis and centrifugation at pH 6. The latter procedure performed at pH 8 dmonstrated that it dissociated into uniform 7S components. The nontoxic component of M toxin was free from hemagglutinin. M toxin alone was demonstrated in culture by sucrose density gradient centrifugation at pH 6. Dialysis of the culture supernatant resulted in partial formation of 16S toxin. Centrifugation of the crystalline toxin in 1 MNaCl demonstrated 16S toxin only. The toxic components of L, M, and crystalline toxins were antigenically identical. The nontoxic components of the crystalline and L toxins, consisting of two distinct antigens, were antigenically identical; that of M toxin was identical with one of these two antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 54335      PMCID: PMC415430          DOI: 10.1128/iai.12.6.1262-1270.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Molecular structures and biological activities of Clostridium botulinum toxins.

Authors:  G Sakaguchi; I Oishi; S Kozaki; S Sakaguchi; M Kitamura
Journal:  Jpn J Med Sci Biol       Date:  1974-04

2.  Heterogeneity of Clstridium botulinum type A toxin.

Authors:  A H Hauschild; R Hilsheimer
Journal:  Can J Microbiol       Date:  1968-07       Impact factor: 2.419

3.  Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration.

Authors:  B R DasGupta; D A Boroff
Journal:  J Biol Chem       Date:  1968-03-10       Impact factor: 5.157

4.  Cation-exchange chromatography of Clostridium botulinum type A toxin on amberlite IRC-50 resin at pH 5.55.

Authors:  B R Dasgupta; D A Boroff; K Cheong
Journal:  Biochim Biophys Acta       Date:  1968-12-03

5.  Purification and some properties of Clostridium botulinum type-E toxin.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  Biochim Biophys Acta       Date:  1968-10-21

6.  Botulinal toxins and the problem of nomenclature of simple toxins.

Authors:  C Lamanna; G Sakaguchi
Journal:  Bacteriol Rev       Date:  1971-09

7.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

8.  Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A.

Authors:  B R Dasgupta; D A Boroff; E Rothstein
Journal:  Biochem Biophys Res Commun       Date:  1966-03-22       Impact factor: 3.575

9.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  33 in total

1.  Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.

Authors:  S Kozaki; A Miki; Y Kamata; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

5.  Observations on toxin and hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Oguma; A Nakane; H Iida
Journal:  Appl Environ Microbiol       Date:  1978-02       Impact factor: 4.792

6.  Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Authors:  F Mark Dunning; Daniel R Ruge; Timothy M Piazza; Larry H Stanker; Füsûn N Zeytin; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

7.  Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Authors:  F Mark Dunning; Timothy M Piazza; Füsûn N Zeytin; Ward C Tucker
Journal:  J Vis Exp       Date:  2014-03-03       Impact factor: 1.355

8.  Positive regulation of botulinum neurotoxin gene expression by CodY in Clostridium botulinum ATCC 3502.

Authors:  Zhen Zhang; Elias Dahlsten; Hannu Korkeala; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2014-10-03       Impact factor: 4.792

9.  Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice.

Authors:  M Inoue; M Kobayashi; S Kozaki; A Zimmer; H Ueda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Oral toxicities of Clostridium botulinum toxins in response to molecular size.

Authors:  I Ohishi; S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.